ClinicalTrials.Veeva

Menu
A

Arthritis and Rheumatology Research Institute | Allen Location

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Deucravacitinib
Upadacitinib
PF-06823859
Icotrokinra
KPL-404
Abiprubart
Afimetoran
JNJ-77242113
Adalimumab
ABBV-154

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 11 total trials

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythema...

Active, not recruiting
Systemic Lupus Erythematosus
Other: Placebo
Drug: Afimetoran

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Enrolling
Systemic Lupus Erythematosus
Other: Placebo
Drug: Deucravacitinib
Locations recently updated

The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

Enrolling
Sjögren's Syndrome
Other: Placebo
Drug: Deucravacitinib

The purpose of this study is to evaluate the efficacy of icotrokinra compared to placebo in biologic-experienced participants with active psoriatic a...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Icotrokinra
Locations recently updated

The purpose of the study is to understand how the study medicine PF-06823859 works in people with idiopathic inflammatory myopathies (DM and PM). The...

Enrolling
Myositis
Drug: PF-06823859
Drug: Placebo

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how s...

Enrolling
Systemic Lupus Erythematosus
Drug: Upadacitinib
Drug: Placebo

Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will assess how...

Active, not recruiting
Rheumatoid Arthritis
Drug: Adalimumab
Drug: Upadacitinib

Trial sponsors

AbbVie logo
Bristol-Myers Squibb (BMS) logo
Janssen (J&J Innovative Medicine) logo
K
Pfizer logo
K

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems